Anixa Biosciences

$4.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (4.04%) Today
+$0.02 (0.49%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ANIX and other stocks, options, ETFs, and crypto commission-free!

About ANIX

Anixa Biosciences, Inc. Common Stock, also called Anixa Biosciences, is harnessing the body's immune system in the fight against cancer. Read More Anixa is developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. Anixa also continually examines emerging technologies in complementary or related fields for further development and commercialization. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Employees
8
Headquarters
San Jose, California
Founded
1982
Market Cap
80.25M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
0.00
High Today
$4.13
Low Today
$3.99
Open Price
$3.99
Volume
44.84K
52 Week High
$6.86
52 Week Low
$3.25

Collections

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.